These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 28326864)

  • 1. Role of the Notch signaling in cholangiocarcinoma.
    Cigliano A; Wang J; Chen X; Calvisi DF
    Expert Opin Ther Targets; 2017 May; 21(5):471-483. PubMed ID: 28326864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corilagin suppresses cholangiocarcinoma progression through Notch signaling pathway in vitro and in vivo.
    Gu Y; Xiao L; Ming Y; Zheng Z; Li W
    Int J Oncol; 2016 May; 48(5):1868-76. PubMed ID: 26935808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of Notch signaling as a therapeutic approach for liver cancer.
    Wu G; Wilson G; George J; Qiao L
    Curr Gene Ther; 2015; 15(2):171-81. PubMed ID: 25537772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Notch signalling beyond liver development: emerging concepts in liver repair and oncogenesis.
    Morell CM; Fiorotto R; Fabris L; Strazzabosco M
    Clin Res Hepatol Gastroenterol; 2013 Nov; 37(5):447-54. PubMed ID: 23806629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholangiocarcinoma: shedding light on the most promising drugs in clinical development.
    Rahnemai-Azar AA; Pawlik TM
    Expert Opin Investig Drugs; 2021 Apr; 30(4):419-427. PubMed ID: 33645382
    [No Abstract]   [Full Text] [Related]  

  • 6. Targeting the tumor microenvironment in cholangiocarcinoma: implications for therapy.
    Louis C; Edeline J; Coulouarn C
    Expert Opin Ther Targets; 2021 Feb; 25(2):153-162. PubMed ID: 33502260
    [No Abstract]   [Full Text] [Related]  

  • 7. Cyclooxygenase-2 and prostaglandin signaling in cholangiocarcinoma.
    Wu T
    Biochim Biophys Acta; 2005 Jul; 1755(2):135-50. PubMed ID: 15921858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Notch signalling pathway in development of cholangiocarcinoma.
    Rauff B; Malik A; Bhatti YA; Chudhary SA; Qadri I; Rafiq S
    World J Gastrointest Oncol; 2020 Sep; 12(9):957-974. PubMed ID: 33005291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signalling networks in cholangiocarcinoma: Molecular pathogenesis, targeted therapies and drug resistance.
    Fouassier L; Marzioni M; Afonso MB; Dooley S; Gaston K; Giannelli G; Rodrigues CMP; Lozano E; Mancarella S; Segatto O; Vaquero J; Marin JJG; Coulouarn C
    Liver Int; 2019 May; 39 Suppl 1():43-62. PubMed ID: 30903728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted Therapies in Cholangiocarcinoma: Emerging Evidence from Clinical Trials.
    Simile MM; Bagella P; Vidili G; Spanu A; Manetti R; Seddaiu MA; Babudieri S; Madeddu G; Serra PA; Altana M; Paliogiannis P
    Medicina (Kaunas); 2019 Feb; 55(2):. PubMed ID: 30743998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JAK-STAT pathway in carcinogenesis: is it relevant to cholangiocarcinoma progression?
    Smirnova OV; Ostroukhova TY; Bogorad RL
    World J Gastroenterol; 2007 Dec; 13(48):6478-91. PubMed ID: 18161917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroendocrine Changes in Cholangiocarcinoma Growth.
    Sato K; Francis H; Zhou T; Meng F; Kennedy L; Ekser B; Baiocchi L; Onori P; Mancinelli R; Gaudio E; Franchitto A; Glaser S; Alpini G
    Cells; 2020 Feb; 9(2):. PubMed ID: 32069926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory Roles of the Notch Signaling Pathway in Liver Repair and Regeneration: A Novel Therapeutic Target.
    Valizadeh A; Sayadmanesh A; Asemi Z; Alemi F; Mahmoodpoor A; Yousefi B
    Curr Med Chem; 2021; 28(41):8608-8626. PubMed ID: 33874861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanism of cholangiocarcinoma carcinogenesis.
    Maemura K; Natsugoe S; Takao S
    J Hepatobiliary Pancreat Sci; 2014 Oct; 21(10):754-60. PubMed ID: 24895231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular pathogenesis of cholangiocarcinoma.
    Berthiaume EP; Wands J
    Semin Liver Dis; 2004 May; 24(2):127-37. PubMed ID: 15192786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Stroma in Cholangiocarcinoma: The Intriguing Interplay between Fibroblastic Component, Immune Cell Subsets and Tumor Epithelium.
    Gentilini A; Pastore M; Marra F; Raggi C
    Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30249019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Notch signaling pathway networks in cancer metastasis: a new target for cancer therapy.
    Li L; Tang P; Li S; Qin X; Yang H; Wu C; Liu Y
    Med Oncol; 2017 Sep; 34(10):180. PubMed ID: 28918490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desmoplastic Tumor Microenvironment and Immunotherapy in Cholangiocarcinoma.
    Høgdall D; Lewinska M; Andersen JB
    Trends Cancer; 2018 Mar; 4(3):239-255. PubMed ID: 29506673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin-mediated regulation of Notch1/hairy and enhancer of split-1/survivin: molecular targeting in cholangiocarcinoma.
    Koprowski S; Sokolowski K; Kunnimalaiyaan S; Gamblin TC; Kunnimalaiyaan M
    J Surg Res; 2015 Oct; 198(2):434-40. PubMed ID: 25890434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenic potential of IDH1R132C mutant in cholangiocarcinoma development in mice.
    Ding N; Che L; Li XL; Liu Y; Jiang LJ; Fan B; Tao JY; Chen X; Ji JF
    World J Gastroenterol; 2016 Feb; 22(6):2071-80. PubMed ID: 26877611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.